Ribomic Inc. provided non-consolidated earnings guidance for the fiscal year ending March 31, 2022. For the period, the company expected operating revenues of JPY 80 million, operating loss of JPY 2,495 million, loss of JPY 2,393 million and loss per share of JPY 85.75.